Evidence map›Paper›PMID 32195351›Full record

ArticleScience advances2020

Inverse control of Rab proteins by

G Stefan Ost, Christophe Wirth, Xenia Bogdanović, Wei-Chun Kao, Björn Schorch, Philipp J K Aktories, Panagiotis Papatheodorou, Carsten Schwan, Andreas Schlosser, Thomas Jank and 2 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Tyrosine-modifying glycosylation by Yersinia effectors.The Journal of biological chemistry · 2024
    Article
  5. Article
  6. Article
  7. Glycosylating Effectors ofBiomolecules · 2022
    Review
  8. Large Clostridial Toxins: Mechanisms and Roles in Disease.Microbiology and molecular biology reviews : MMBR · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

G Stefan OstInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany.ORCID 0000-0001-5837-3537
Christophe WirthInstitut für Biochemie und Molekularbiologie, ZBMZ, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany.ORCID 0000-0001-8864-6508
Xenia BogdanovićInstitut für Biochemie und Molekularbiologie, ZBMZ, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany.
Wei-Chun KaoInstitut für Biochemie und Molekularbiologie, ZBMZ, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany.ORCID 0000-0001-8687-6334
Björn SchorchInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany.ORCID 0000-0001-8311-0210
Philipp J K AktoriesInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany.
Panagiotis PapatheodorouInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany.
Carsten SchwanInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany.
Andreas SchlosserRudolf-Virchow-Zentrum für Experimentelle Biomedizin, Universität Würzburg, 97080 Würzburg, Germany.ORCID 0000-0003-0612-9932
Thomas JankInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany.
Carola HunteInstitut für Biochemie und Molekularbiologie, ZBMZ, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany.ORCID 0000-0002-0826-3986
Klaus AktoriesInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, 79104 Freiburg, Germany.ORCID 0000-0002-5397-0436
University of Freiburg · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We identified a glucosyltransferase (YGT) and an ADP-ribosyltransferase (YART) in

Indexed as

ADP Ribose TransferasesBacterial ProteinsBacterial ToxinsGlycosyltransferasesYersiniaCrystallography, X-RayGlucosyltransferasesGlycosylationHeLa CellsHumansProtein Domainsrab5 GTP-Binding Proteinsrab GTP-Binding ProteinsUridine DiphosphateADP Ribose TransferasesBacterial ProteinsBacterial ToxinsGlucosyltransferasesGlycosyltransferasesRAB31 protein, humanRAB5C protein, humanrab5 GTP-Binding Proteinsrab GTP-Binding ProteinsUridine Diphosphate

Identifiers

PMID32195351
PMCPMC7065874
OpenAlexW3011383713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.